Navigation Links
Derma Sciences Reports Fourth Quarter, Year-End Results for 2008
Date:4/1/2009

rietary lines now include the TCC-EZ(TM) Total Contact Casting system, XTRASORB(TM) Super Absorbent Dressings and the MOBILITY1(TM) Intermittent Pneumatic Compression Therapy system for ambulatory patients. Last month we received clearance from the Food and Drug Administration for the marketing and sale of BIOGUARD(TM) Barrier Dressings, our novel line of infection control products. We are also pleased to report that patients are currently enrolling into the Phase II efficacy study of DSC127, a novel angiotensin analog licensed from the University of Southern California in November 2007 for use in wound healing and scar reduction. The great synergies between all these innovative products will get us closer to our goal of becoming a leader in the $4.1 billion advanced wound care market."

At December 31, the Company had a current ratio of 1.6:1. Total assets were $36.2 million vs total liabilities of $14.8 million. Shareholder's equity grew to $21.4 million, or approximately $0.53 per share. Quilty pointed out that the Company's common stock is trading below book value, in spite of growing sales and successful proprietary products added to the company's portfolio. "It's a sign of the times," he said, "but clearly not a satisfactory valuation from our point of view. We will stick to our strategic plan, reduce expenses wherever we are able to without adversely affecting our products and customer service, and continue to build sales and value for our shareholders.

"Getting through a difficult economic time like this requires hard work and dedication on the part of our staff, and a willingness to follow financial priorities rigorously," Quilty continued. "The integration of our FAD acquired in November 2007 was more costly than we had expected in 2008, and we had to continue working in a high-cost plant until we successfully transitioned manufacturing. Although that manufacturing transition took significantly longer t
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009
2. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
3. Wendy E. Roberts, MD, Named 2009-2010 President of the Womens Dermatologic Society
4. Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil.
5. Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting
6. Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
7. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
8. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
9. Professional Skin Care Company OrthoNeutrogena Becomes Ortho Dermatologics
10. American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies
11. Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... September 21, 2014 Market ... (CAS 49562-28-9) Industry, 2009-2019 is a professional ... Chinese Fenofibrate (CAS 49562-28-9) industry. The report ... (CAS 49562-28-9) including its classification, application and ... China’s top manufacturers of Fenofibrate (CAS 49562-28-9) ...
(Date:9/21/2014)... September 21, 2014 “Cluster headaches are ... intense and difficult to resolve,” said Steve Young of ... think of a pain that is more intense.” , ... from cluster headaches, or migraines, that medical research is ... serotonin system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is ...
(Date:9/21/2014)... September 21, 2014 According to latest ... highest birth rate since 1966 (10.5 births per 1,000 women ... early 40s has risen steadily by 2 percent per year. ... to women aged 50 and over) also rose, the first ... were more than nine times as many first births to ...
(Date:9/20/2014)... Weight Destroyer , a weight loss ... Wren that has already helped tens of thousands of ... like high blood pressure, high cholesterol, and accelerated aging ... investigative review. , “Weight Destroyer is totally turning ... showing people what is truly effective when it comes ...
(Date:9/20/2014)... Increases in household, construction and commercial ... volumes. However, government regulations and higher landfill disposal ... to IBISWorld industry analyst Alen Allday, “over the ... reducing the volume of waste generated, and increasing ... a large proportion of waste generated by households ...
Breaking Medicine News(10 mins):Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3
... Provider of Affordable Health Insurance Points to President,s Suggestion that ... , AVENTURA, Fla., June 23 Cinergy ... programs for the consumer market, expressed its approval with remarks ... , "As politicians from both sides of the aisle ...
... researchers say , TUESDAY, June 23 (HealthDay News) -- A ... a small study shows. , In the new study, researchers ... (PTMA) system, which is installed via a catheter. , In ... from the left atrium into the left ventricle (from the ...
... need for pacemaker, early death, study shows , TUESDAY, ... an electrocardiogram (EKG), until now thought to be insignificant, ... and an increased risk of early death, a new ... PR interval, the right-hand portion of the jagged blip ...
... are overweight or obese have an increased risk of pancreatic ... with a lower overall survival rate for patients with pancreatic ... of JAMA . Pancreatic cancer is the ... women in the United States. As the prevalence of overweight ...
... ... , ... (PRWEB) June 23, 2009 -- Connextions Inc. today announced the appointment of ... responsibility for management of the company,s 12-member development team at its Technology Center in ...
... ... Chester and Delaware Counties Go Back to School , ... Philadelphia (Vocus) June 23, 2009 -- ... will be awarding scholarships, totaling $82,000, to 41 of its members, on Tuesday, June ...
Cached Medicine News:Health News:Cinergy Health Commentary On President Obama's Call for Cost Control, Competition in Health Insurance Arena 2Health News:New Heart Valve Repair System Tested for Safety 2Health News:Electrocardiogram Blip Signals Heart Trouble 2Health News:Electrocardiogram Blip Signals Heart Trouble 3Health News:Being overweight, obese during early adulthood associated with greater risk of pancreatic cancer 2Health News:Being overweight, obese during early adulthood associated with greater risk of pancreatic cancer 3Health News:Connextions, Inc. Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 2Health News:Connextions, Inc. Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 3Health News:41 Keystone Mercy Health Plan Members to Receive Scholarships from the Plan's Employees 2
(Date:9/19/2014)... , Sept. 19, 2014 Five MinuteClinic walk-in medical clinics ... metropolitan area. Three clinics opened in Memphis ... A fourth clinic will be added in Springfield ... Bartlett is expected to open October 22.  MinuteClinic is ... the United States . The ...
(Date:9/19/2014)...  Lpath, Inc. (NASDAQ: LPTN ), ... today that it has entered into definitive agreements ... and 3,605,042 unregistered warrants in a registered direct ... share of common stock and one unregistered warrant ... will be $3.475.  The warrants have an exercise ...
(Date:9/19/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... ITCA 650 (continuous subcutaneous delivery of exenatide) in type ... the 50 th Annual Meeting of the European ... the open-label, phase 3 FREEDOM-HBL (high baseline) trial showed ... poorly controlled type 2 diabetes. The results were presented ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... 26, 2007 - A new study published ... ("A National Survey of,Physician-Industry Relationships") on the ... the need for,profession-wide and public policy reforms ... that the existing,voluntary PhRMA (Pharmaceutical Research and ...
... 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced today ... of the Journal of Neuroscience a study,by ... National Jewish,Medical and Research Center demonstrating that ... 11207, demonstrated,neuroprotection in an animal model of ...
Cached Medicine Technology:Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3
... The advanced performance benefits of TiMAX™ ... generation of implants. DePuy ACEs Large Fragment ... biocompatibility and enhanced imaging compatibility over traditional ... unique thread design in the TiMAX bone ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... Fragment System has been conceived and engineered ... and user-friendly instrumentation. The modular system of ... instrumentation is designed to provide the surgeon ... and classic techniques of open reduction and ...
Medicine Products: